Thursday, September 6, 2012

Sonitus Medical Announces First European Commercialization with Shipment of SoundBite Hearing System to Seven Centers of Excellence


SAN MATEO, Calif.Sept. 6, 2012-- Sonitus Medical, Inc., a medical device company that manufactures the world's first non-surgical and removable hearing device to transmit sound via the teeth, today is announcing the global commercialization and a limited market launch in Europe of its SoundBite Hearing System.  The first deployment of its prosthetic devices throughout Europe is a measured roll out to seven centers of excellence in key markets in order to conduct a multi-site evaluation of the SoundBite prosthetic device. 
"This is a major milestone for our company as we begin to establish a commercial network for SoundBite in Europe," said Amir Abolfathi, CEO of Sonitus Medical. "We are gratified to be working with esteemed hearing specialists in the EU medical community to undertake this post-market evaluation which will document long-term utilization and patient experience."
The SoundBite Hearing System received CE Mark certification in The European Union for the treatment of single sided deafness, or patients who are essentially deaf in one ear, those with conductive hearing loss, and those with mixed hearing loss.
SoundBite uses bone conduction to deliver clear, high quality sound to the inner ear.  Many familiar sounds are heard through bone conduction; for example chattering teeth, crunching on potato chips, or scratching the scalp. Nearly invisible when worn, the SoundBite system consists of an easy to insert and remove in-the-mouth hearing device and a small microphone unit worn behind the ear.